Severe colchicine poisoning treated successfully with kidney replacement therapy and plasmapheresis: a case report.

IF 0.3 4区 历史学 0 ARCHAEOLOGY Britannia Pub Date : 2022-01-01 Epub Date: 2022-03-24 DOI:10.1080/24734306.2022.2055817
D H Schaffer, D L Overbeek, T B Erickson, E W Boyer, C Goldfine, S A Muhsin, P R Chai
{"title":"Severe colchicine poisoning treated successfully with kidney replacement therapy and plasmapheresis: a case report.","authors":"D H Schaffer, D L Overbeek, T B Erickson, E W Boyer, C Goldfine, S A Muhsin, P R Chai","doi":"10.1080/24734306.2022.2055817","DOIUrl":null,"url":null,"abstract":"<p><p>Colchicine is commonly prescribed for treatment of inflammatory conditions but has a narrow therapeutic window and dangerous toxicity profile. Here we describe a case of survival after massive unintentional colchicine overdose treated with plasmapheresis and renal replacement therapy. A 37 year old male with history of pericarditis presented to the Emergency Department with a chief complaint of nausea, vomiting, and diarrhea after unintentionally ingesting 36 mg of colchicine 17 h prior to arrival. An initial colchicine concentration resulted at 5.1 ng/mL (30 h post-ingestion) and peaked at 12 ng/mL (40 h post-ingestion). He was treated with continuous kidney replacement therapy (CKRT) beginning on his first day of hospitalization and with plasmapheresis on hospital days two through four. The patient's course was complicated by multiorgan failure including coagulopathy, respiratory failure, neuropathy, renal failure, pancytopenia, and heart failure. He was discharged to inpatient rehabilitation on hospital day 24. On clinical follow up four months after discharge the patient was found to have no significant persistent morbidity related to colchicine overdose.</p>","PeriodicalId":44906,"journal":{"name":"Britannia","volume":"5 1","pages":"47-51"},"PeriodicalIF":0.3000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049641/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Britannia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/24734306.2022.2055817","RegionNum":4,"RegionCategory":"历史学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/3/24 0:00:00","PubModel":"Epub","JCR":"0","JCRName":"ARCHAEOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Colchicine is commonly prescribed for treatment of inflammatory conditions but has a narrow therapeutic window and dangerous toxicity profile. Here we describe a case of survival after massive unintentional colchicine overdose treated with plasmapheresis and renal replacement therapy. A 37 year old male with history of pericarditis presented to the Emergency Department with a chief complaint of nausea, vomiting, and diarrhea after unintentionally ingesting 36 mg of colchicine 17 h prior to arrival. An initial colchicine concentration resulted at 5.1 ng/mL (30 h post-ingestion) and peaked at 12 ng/mL (40 h post-ingestion). He was treated with continuous kidney replacement therapy (CKRT) beginning on his first day of hospitalization and with plasmapheresis on hospital days two through four. The patient's course was complicated by multiorgan failure including coagulopathy, respiratory failure, neuropathy, renal failure, pancytopenia, and heart failure. He was discharged to inpatient rehabilitation on hospital day 24. On clinical follow up four months after discharge the patient was found to have no significant persistent morbidity related to colchicine overdose.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
通过肾脏替代疗法和血浆置换术成功治疗严重秋水仙碱中毒:一份病例报告。
秋水仙碱是治疗炎症的常用处方药,但其治疗窗口较窄,且具有危险的毒性。在这里,我们描述了一例通过血浆置换术和肾脏替代疗法治疗大量意外过量秋水仙碱后存活的病例。一名有心包炎病史的 37 岁男性在抵达急诊科 17 小时前无意中摄入 36 毫克秋水仙碱,主诉恶心、呕吐和腹泻。最初的秋水仙碱浓度为 5.1 纳克/毫升(摄入后 30 小时),最高浓度为 12 纳克/毫升(摄入后 40 小时)。从住院第一天开始,他接受了持续肾脏替代疗法(CKRT),并在住院第二至四天接受了血浆置换术。凝血功能障碍、呼吸衰竭、神经病变、肾功能衰竭、泛血细胞减少和心力衰竭等多器官功能衰竭使患者的病程变得更加复杂。他在住院第 24 天康复出院。出院 4 个月后的临床随访发现,患者并没有因秋水仙碱过量而出现明显的持续发病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Britannia
Britannia Multiple-
CiteScore
0.70
自引率
50.00%
发文量
35
期刊介绍: Information not localized
期刊最新文献
III. INSCRIPTIONS BRI volume 54 Cover and Back matter II. FINDS REPORTED UNDER THE PORTABLE ANTIQUITIES SCHEME ENGLAND 3. HADRIAN'S WALL I. SITES EXPLORED 1. WALES
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1